• 1
    Goldman AB, DiCarlo EF. Pigmented villonodular synovitis. Diagnosis and differential diagnosis. Radiol Clin North Am. 1988; 26: 1327-1347.
  • 2
    Jaffe H, Lichtenstein L, Sutro C. Pigmented villonodular synovitis, bursitis and tenosynovitis: a discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor or myeloplaxoma of tendon sheath with some consideration of this tendon sheath lesion itself. Arch Pathol. 1941; 31: 731-765.
  • 3
    Flandry F, Norwood LA. Pigmented villonodular synovitis of the shoulder. Orthopedics. 1989; 12: 715-718.
  • 4
    Oehler S, Fassbender HG, Neureiter D, Meyer-Scholten C, Kirchner T, Aigner T. Cell populations involved in pigmented villonodular synovitis of the knee. J Rheumatol. 2000; 27: 463-470.
  • 5
    Abdul-Karim FW, el-Naggar AK, Joyce MJ, Makley JT, Carter JR. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol. 1992; 23: 729-735.
  • 6
    Fletcher JA, Henkle C, Atkins L, Rosenberg AE, Morton CC. Trisomy 5 and trisomy 7 are nonrandom aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells. Genes Chromosomes Cancer. 1992; 4: 264-266.
  • 7
    Perka C, Labs K, Zippel H, Buttgereit F. Localized pigmented villonodular synovitis of the knee joint: neoplasm or reactive granuloma? A review of 18 cases. Rheumatology (Oxford). 2000; 39: 172-178.
  • 8
    Ray RA, Morton CC, Lipinski KK, Corson JM, Fletcher JA. Cytogenetic evidence of clonality in a case of pigmented villonodular synovitis. Cancer. 1991; 67: 121-125.
  • 9
    Bertoni F, Unni KK, Beabout JW, Sim FH. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol. 1997; 21: 153-163.
  • 10
    Nielsen AL, Kiaer T. Malignant giant cell tumor of synovium and locally destructive pigmented villonodular synovitis: ultrastructural and immunohistochemical study and review of the literature. Hum Pathol. 1989; 20: 765-771.
  • 11
    Rao AS, Vigorita VJ. Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane). A review of eighty-1 cases. J Bone Joint Surg Am. 1984; 66: 76-94.
  • 12
    Docken WP. Pigmented villonodular synovitis: a review with illustrative case reports. Semin Arthritis Rheum. 1979; 9: 1-22.
  • 13
    Granowitz SP, D'Antonio J, Mankin HL. The pathogenesis and long-term end results of pigmented villonodular synovitis. Clin Orthop Relat Res. 1976;( 114): 335-351.
  • 14
    Ogilvie-Harris DJ, McLean J, Zarnett ME. Pigmented villonodular synovitis of the knee. The results of total arthroscopic synovectomy, partial, arthroscopic synovectomy, and arthroscopic local excision. J Bone Joint Surg Am. 1992; 74: 119-123.
  • 15
    Schwartz HS, Unni KK, Pritchard DJ. Pigmented villonodular synovitis. A retrospective review of affected large joints. Clin Orthop Relat Res. 1989;( 247): 243-255.
  • 16
    Friedman M, Schwartz EE. Irradiation therapy of pigmented villonodular synovitis. Bull Hosp Joint Dis. 1957; 18: 19-32.
  • 17
    Greenfield MM, Wallace KM. Pigmented villonodular synovitis. Radiology. 1950; 54: 350-356.
  • 18
    Horoschak M, Tran PT, Bachireddy P, et al. External beam radiation therapy enhances local control in pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys. 2009; 75: 183-187.
  • 19
    Lee M, Mahroof S, Pringle J, Short SC, Briggs TW, Cannon SR. Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy. Int Orthop. 2005; 29: 403-405.
  • 20
    Berger B, Ganswindt U, Bamberg M, Hehr T. External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys. 2007; 67: 1130-1134.
  • 21
    Blanco CE, Leon HO, Guthrie TB. Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee. Arthroscopy. 2001; 17: 527-531.
  • 22
    Wu CC, Pritsch T, Bickels J, Wienberg T, Malawer MM. Two incision synovectomy and radiation treatment for diffuse pigmented villonodular synovitis of the knee with extra-articular component. Knee. 2007; 14: 99-106.
  • 23
    Franssen MJ, Boerbooms AM, Karthaus RP, Buijs WC, van de Putte LB. Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements. Ann Rheum Dis. 1989; 48: 1007-1013.
  • 24
    Chin KR, Barr SJ, Winalski C, Zurakowski D, Brick GW. Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee. J Bone Joint Surg Am. 2002; 84A: 2192-2202.
  • 25
    O'sullivan MM, Yates DB, Pritchard MH. Yttrium 90 synovectomy—a new treatment for pigmented villonodular synovitis. Br J Rheumatol. 1987; 26: 71-72.
  • 26
    Shabat S, Kollender Y, Merimsky O, et al. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology (Oxford). 2002; 41: 1113-1118.
  • 27
    O'sullivan B, Cummings B, Catton C, et al. Outcome following radiation treatment for high-risk pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys. 1995; 32: 777-786.
  • 28
    Davis AM, Wright JG, Williams JI, Bombardier C, Griffin AM, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996; 5: 508-516.
  • 29
    Enneking W. Modification of the system for functional evaluation of the surgical management of musculoskeletal tumors. In: Enneking W, ed. Limb Salvage in Musculoskeletal Oncology. New York: Churchill Livingstone; 1987: 626-639.
  • 30
    Enneking WF, Dunham W, Gebhardt MC, Malawar M, Prichard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop. 1993; 286: 241-246.
  • 31
    Chin KR, Brick GW. Extraarticular pigmented villonodular synovitis: a cause for failed knee arthroscopy. Clin Orthop Relat Res. 2002;( 404): 330-338.
  • 32
    Holt GE, Griffin AM, Pintilie M, et al. Fractures following radiotherapy and limb salvage surgery for lower extremity soft tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg (Am). 2005; 87A: 315-319.
  • 33
    Wiss DA. Recurrent villonodular synovitis of the knee. Successful treatment with yttrium-90. Clin Orthop Relat Res. 1982;( 169): 139-144.
  • 34
    Bickels J, Isaakov J, Kollender Y, Meller I. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis. J Bone Joint Surg Am. 2008; 90: 326-328.
  • 35
    Kampen WU, Voth M, Pinkert J, Krause A. Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications. Rheumatology (Oxford). 2007; 46: 16-24.
  • 36
    Stucki G, Bozzone P, Treuer E, Wassmer P, Felder M. Efficacy and safety of radiation synovectomy with yttrium-90: a retrospective long-term analysis of 164 applications in 82 patients. Br J Rheumatol. 1993; 32: 383-386.
  • 37
    Geldyyev A, Koleganova N, Piecha G, et al. High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis. Cancer Lett. 2007; 255: 275-283.
  • 38
    West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A. 2006; 103: 690-695.
  • 39
    Cupp JS, Miller MA, Montgomery KD, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007; 31: 970-976.
  • 40
    Blay JY, El Sayadi H, Thiesse P, Garret J, Ray-Coquard I. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol. 2008; 19: 821-822.
  • 41
    O'Dea FJ, Wunder J, Bell RS, Griffin AM, Catton C, O'sullivan B. Preoperative radiotherapy is effective in the treatment of fibromatosis. Clin Orthop Relat Res. 2003;( 415): 19-24.
  • 42
    Miralbell R, Suit HD, Mankin HJ, Zuckerberg LR, Stracher MA, Rosenberg AE. Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1990; 18: 535-540.
  • 43
    Guadagnolo BA, Zagars GK, Ballo MT. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008; 71: 441-447.